Tag Archives: Daniel Lopez

Belviq®: A Novel Multipotential Therapeutic and Preventative Anti-Obesity Medication

Belviq® is an anti-obesity drug, but it also potentially helps with treating Type 2 Diabetes (Diabetes Mellitus) and other co-morbidities, including metabolic syndrome (abdominal obesity, hyperglycemia, dyslipidemia, and hypertension).  Belviq® also potentially improves many other indications, including asthma and smoking cessation (nicotine addiction).

http://beta.fool.com/bruinmd/2012/09/27/belviq-novel-diamond-ruff-treatment-obesity-and-re/12601/